Skip to main content
Clinical Trials/NCT02244645
NCT02244645
Unknown
Not Applicable

Effects of Yoga Versus Passive Modality on Pain, Disability, Salivary Cortisol Concentrations, Brain- Derived Neurotropic Factor, Heart Rate Variability and Immune Functions Among Patients With Chronic Low Back Pain: A Randomized Controlled Trial

Chang Bing Show Chwan Memorial Hospital1 site in 1 country86 target enrollmentStarted: December 2013Last updated:
ConditionsLow Back Pain

Overview

Phase
Not Applicable
Enrollment
86
Locations
1
Primary Endpoint
Back pain relief and functional life improved

Overview

Brief Summary

This study may clarify a potential promising mechanism and clearest evidence to support the value of yoga as a therapeutic option for reducing chronic low back pain.

Detailed Description

Low back pain is a common problem, with 70-80% of adults were bothered in their lives, which influence the work and quality of life. Yoga is one of the most popular complementary and alternative medicine for back pain, and this mind-body intervention has increasingly chosen to effectively treat chronic pain.

This is a parallel-arm randomized controlled trial which will compare the outcomes of participants assigned to the experimental treatment group (yoga, with 36 participants) with those assigned to a passive modality control group for 3 months (12 weeks). Each group will receive regular 60-minutes yoga classes or passive modality twice a week. The investigators confer the difference of pain relief and functional life improvement between passive modality and yoga. The latter is expected to have positive effects on Chronic low back pain. The effects and possible mechanisms of action responsible for passive modality and yoga on salivary cortisol concentrations, inflammatory cytokines and autonomic nervous tone will be also evaluated. The study's primary endpoints are (1) back pain relief, (2) functional life improved, (3) Salivary cortisol concentrations decreased, (4) brain-derived neurotrophic factor improved, (5) heart rate variability improved, and (6) immune function improved significantly among the participants in the experimental group than the control group.

This study may clarify a potential promising mechanism and clearest evidence to support the value of yoga as a therapeutic option for reducing chronic low back pain. If the results are positive, clinicians will attain more options for treating patient with chronic low back. Furthermore, the positive results from this study will help focus more future in-depth research on the most promising potential mechanism of action identifies.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
20 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patient with idiopathic low back pain of more than 12 weeks.

Exclusion Criteria

  • Current pregnancy
  • Diagnosis of ankylosing spondylitis, osteoporosis, fibromyalgia, failed back syndrome and other chronic illnesses.
  • Inability to participate yoga exercise regularly.
  • Accept steroid treatment within 3 months.
  • BMI \> 30

Outcomes

Primary Outcomes

Back pain relief and functional life improved

Time Frame: Change from baseline in back pain and life quality at 6 months

Back pain relief and functional life improved will assessed by visual analogue scale (VAS) and Roland-Morris disability questionnaire at five different times: (1)baseline data : before intervention, (2)outcome data: 3, 6, 9 and 12 week yoga exercise, right after exercise measure post-test.

Secondary Outcomes

  • Salivary cortisol concentrations decreased(Change from baseline in salivary cortisol at 6 months)
  • Heart rate variability improved(Change from baseline in heart rate variability at 6 months)
  • Immune function improved(Change from baseline in immune function at 6 months)
  • Brain-derived neurotrophic factor improved(Change from baseline in brain-derived neurotrophic factor at 6 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Shu-Hui Yeh

RN, PhD, Professor

Chang Bing Show Chwan Memorial Hospital

Study Sites (1)

Loading locations...

Similar Trials